Atriva TherapeuticsTherapies against viral infections. More Info The Atriva Approach First-in-class host-targeting therapies to treat respiratory viral infections, including COVID-19 and influenza. Great potential against a wide variety of respiratory viruses due to immunomodulating and antivira ...
Location: Germany, Baden-Württemberg, Tübingen
Employees: 1-10
Total raised: $10.19M
Founded date: 2015
Investors 2
| Date | Name | Website |
| - | Meneldor | meneldor.n... |
| - | High-Tech ... | htgf.de |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.08.2020 | - | $10.19M | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 21.10.2022 | Former Allergan exec heads to Revance as it challenges... | David Hollander → Revance feels like it has a competitive advantage over AbbVie’s blockb... | endpts.com... |
| 25.03.2022 | Roger Perlmutter lures Roy Baynes away from Merck; Now, Voya... | Roy Baynes → Professional sports teams cycle through free agency every year, and core veterans from... | endpts.com... |
| 10.01.2022 | Atriva receives FDA Orphan Drug Designation for Zapnometinib... | DGAP-News: Atriva Therapeutics GmbH / Key word(s): Regulatory Admission Atriva receives FDA Orphan ... | marketscre... |
| 16.04.2021 | Novavax CFO Greg Covino makes a quick exit as leadershi... | Greg Covino → If it seems like Covid-19 vaccine bridesmaid Novavax is shuttling staffers in an... | endpts.com... |
| 13.04.2021 | Atriva Therapeutics GmbH : Announces Changes to Management | DGAP-News: Atriva Therapeutics GmbH / Key word(s): Personnel Atriva Therapeutics Announces Changes ... | marketscre... |
| 19.08.2020 | Atriva Therapeutics Closes €8.6M Oversubscribed Convertible ... | Atriva Therapeutics, a Tübingen and Frankfurt, Germany-based biopharmaceutical company developing ho... | finsmes.co... |
| 11.01.2019 | Atriva Therapeutics Raises Initial Series A Funding | Atriva Therapeutics, a Tübingen, Germany-based biopharmaceutical company developing host-targeting a... | finsmes.co... |
| 22.09.2017 | Atriva Receives Additional Tranche of Seed Financing | Atriva Therapeutics GmbH, a Tübingen, Germany-based developer of innovative antiviral therapies, rai... | finsmes.co... |
| 08.02.2017 | Atriva Raises Seed Funding Round | Atriva Therapeutics, a Tübingen, Germany-based developer of an innovative influenza therapeutic, rai... | finsmes.co... |
| - | HTGF portfolio company: EIB backs Atriva Therapeutics with €... | October 20, 2020 The European Investment Bank (EIB) and Atriva Therapeutics GmbH, a biopharmaceutic... | htgf.de/en... |
Show more